QC
IRON icon

Quadrature Capital’s Disc Medicine IRON Stock Holding History

Quadrature Capital’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Buy
+42,419
New +$2.91M 0.03% 396

Other funds holding IRON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Quadrature Capital's IRON Position: Q2 2026 in Review

Quadrature Capital opened a new position in Disc Medicine (IRON) in Q2 2026: 42,419 shares worth $3.1M. The stake represents 0.03% of the portfolio and ranks #396 among its holdings.

58 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Quadrature Capital held 42,419 shares of Disc Medicine worth $3.1M as of Q2 2026.
  • Disc Medicine was a new Quadrature Capital position in Q2 2026.
  • Disc Medicine made up 0.03% of Quadrature Capital's portfolio in Q2 2026, its #396 holding.
  • 58 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.